The International formation IsDD, created in 2010, responds to a request from the private sector (pharmaceutical companies) and the academic sector, to train students to design future medicines using computational approaches (in silico), and to accelerate the process of research for new therapeutic drugs. This IsDD training course offers high-level scientific training in a rapidly expanding field of drug discovery research, and offers many opportunities both nationally and internationally, opening the doors to the professional world in the public and the private sector.
This IsDD major, with a professional and research focus, supplements the training programme in Life Sciences and Chemistry through a training course with strong implications in the field of Health, whose cornerstone is interdisciplinarity. This interdisciplinarity is supported by excellence masters from several French and European universities (Paris Diderot, Strasbourg, DegliStudi di Milano), and byacademic and private sector “excellence” teams, with the participation of many international specialists from different countries.
This international major in IsDD offers two internationally oriented courses, which include many modules taught in English, an internship and/or study semester, and open internships abroad. It has international recognition.
The « Design bioactive molecules, IsDD-Bioactive Molecules » course offers the possibility of validating a double Franco-Italian diploma with the University degli studi in Milano (Milan).
The « Analysis of macromolecular complexes of drugs, IsDD-Macromolecules » course offers the possibility of validating a double Franco-Russian diploma with the University of Sechenov (Moscow). This course can also be done alternately.
This «In Silico Drug Design» formation offers all the additional knowledge necessary for
research processes of new therapeutic drugs, «Drug Discovery» via computer applications (in silico).
Students will gain solid knowledge of chemical compounds, and their toxicity and therapeutic
targets (biological macromolecules), biochemistry and physics-chemistry, as well as concepts
of medicinal chemistry and molecular medicine. They will acquire advanced skills on
computer modelling of target interactions-chemical molecules. They will be trained in the
modelling, analysis and prediction of therapeutic drugs, biological targets, and drug-target
interactions. For example, in silico approaches such as biostatistics and data analysis
(«QSAR»), programming, chemoinformatics, structural bioinformatics, molecular dynamics
and modelling, docking methods, and virtual screening will be addressed.